Stryker Corporation (SYK)

Currency in USD
369.56
+15.26(+4.31%)
Closed·
368.20-1.36(-0.37%)
·
SYK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
363.48375.92
52 wk Range
329.16404.87
Key Statistics
Prev. Close
369.56
Open
369.1
Day's Range
363.48-375.92
52 wk Range
329.16-404.87
Volume
3.32M
Average Vol. (3m)
1.8M
1-Year Change
-5.5534%
Book Value / Share
58.63
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SYK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
424.40
Upside
+14.84%
Members' Sentiments
Bearish
Bullish
ProTips
12 analysts have revised their earnings downwards for the upcoming period

Stryker Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Stryker Corporation Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Stryker Corporation SWOT Analysis


Analyst Optimism
Learn about analyst perspectives, with price targets ranging from $435 to $450, reflecting confidence in Stryker's growth potential
Financial Resilience
Discover Stryker's robust financial performance, with double-digit revenue growth and margin expansion, despite industry challenges
Robotic Surgery Leade
Delve into Stryker's dominance in robotic surgery with the Mako system, driving innovation and market share in orthopedic procedures
Strategic Reshaping
Explore Stryker's portfolio transformation, including the Inari Medical acquisition and Spinal Implants divestiture, aimed at high-growth market segments
Read full SWOT analysis

Stryker Corporation Earnings Call Summary for Q4/2025

  • Stryker reported Q4 2025 EPS of $4.47 (beating $4.39 forecast) and revenue of $7.2 billion (above $7.12B expected), with 11% organic sales growth and full-year sales exceeding $25 billion.
  • Despite strong earnings, Stryker's stock dipped 0.99% in after-hours trading to $357.79, possibly reflecting broader market concerns or profit-taking.
  • The Mako robotic system, now with over 3,000 installations worldwide, continues to drive growth, with U.S. market showing 11.2% organic growth versus 7.5% in international markets.
  • For 2026, Stryker forecasts organic sales growth of 8-9.5% and adjusted EPS of $14.90-$15.10, though tariffs are expected to cost $400 million, potentially affecting margins.
  • CEO Kevin Lobo expressed confidence in 'delivering growth at the high end of medtech' in 2026, highlighting the company's strong financial position for potential M&A opportunities.
Last Updated: 01/29/2026, 06:06 PM
Read Full Transcript

Compare SYK to Peers and Sector

Metrics to compare
SYK
Peers
Sector
Relationship
P/E Ratio
43.5x24.2x−0.6x
PEG Ratio
5.28−0.280.00
Price / Book
6.3x5.2x2.6x
Price / LTM Sales
5.6x3.3x3.4x
Upside (Analyst Target)
15.7%0.0%44.9%
Fair Value Upside
Unlock19.5%6.3%Unlock

Analyst Ratings

21 Buy
8 Hold
1 Sell
Ratings:
30 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 424.40
(+14.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Hold395.00+6.88%392.00MaintainJan 30, 2026
Needham
Buy454.00+22.85%448.00MaintainJan 30, 2026
Baird
Buy437.00+18.25%450.00MaintainJan 30, 2026
Canaccord Genuity
Buy435.00+17.71%-MaintainJan 30, 2026
Citizens
Buy440.00+19.06%-MaintainJan 30, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.40%
Dividend Yield
0.95%
Industry Median 1.34%
Annualized Payout
3.52
Paid quarterly
5-Years Growth
+7.62%
Growth Streak

Earnings

Latest Release
Jan 29, 2026
EPS / Forecast
4.47 / 4.39
Revenue / Forecast
7.20B / 7.12B
EPS Revisions
Last 90 days

SYK Income Statement

People Also Watch

359.22
COR
+2.02%
576.25
SNDK
+6.85%
241.05
TER
-4.30%
214.88
CAH
+1.73%
223.01
ABBV
+1.17%

FAQ

What Is the Stryker (SYK) Stock Price Today?

The Stryker stock price today is 369.56

What Stock Exchange Does Stryker Trade On?

Stryker is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Stryker?

The stock symbol for Stryker is "SYK."

Does Stryker Pay Dividends? What’s The Current Dividend Yield?

The Stryker dividend yield is 0.95%.

What Is the Stryker Market Cap?

As of today, Stryker market cap is 141.33B.

What Is Stryker's Earnings Per Share (TTM)?

The Stryker EPS (TTM) is 8.40.

When Is the Next Stryker Earnings Date?

Stryker will release its next earnings report on May 06, 2026.

From a Technical Analysis Perspective, Is SYK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Stryker Stock Split?

Stryker has split 9 times.

How Many Employees Does Stryker Have?

Stryker has 53000 employees.

What is the current trading status of Stryker (SYK)?

As of Feb 02, 2026, Stryker (SYK) is trading at a price of 369.56, with a previous close of 369.56. The stock has fluctuated within a day range of 363.48 to 375.92, while its 52-week range spans from 329.16 to 404.87.

What Is Stryker (SYK) Price Target According to Analysts?

The average 12-month price target for Stryker is USD424.40, with a high estimate of USD469 and a low estimate of USD316. 21 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +14.84% Upside potential.

What Is the SYK Premarket Price?

SYK's last pre-market stock price is 368.20. The pre-market share volume is 120.00, and the stock has decreased by -1.36, or -0.37%.

What Is the SYK After Hours Price?

SYK's last after hours stock price is 369.66, the stock has decreased by 0.10, or 0.03%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.